pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

17 catalysts · 607 approval · 37 phase readout · 29 drug shortage · 17 recall · 5 8k filing · 5 grant

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts2026-11-23: 0 catalysts2026-11-24: 0 catalysts2026-11-25: 0 catalysts2026-11-26: 0 catalysts2026-11-27: 0 catalysts2026-11-28: 0 catalysts2026-11-29: 0 catalysts
view
agendamonth
hide past →
sort
soonestlatesttypesponsoralpha
matching 'Pfizer'×type: recall×clear all
type
  • approval607
  • phase readout37
  • drug shortage29
  • recall17
  • 8k filing5
  • grant5
  • earnings4
  • device recall3
  • device pma2
  • phase 2 completion2
  • therapy area

    no tagged catalysts yet

    Week of Feb 3, 2025

    1
    ›Feb 5, 2025recall579d agoMcKesson recall (Cls II)MCKESSON CORP

    Inflectra (infliximab-dyyb), For injection, 100mg per vial, packaged in 10 mL single-dose vial, Rx only, Mfd by: CELLTRION, INC, Dist. by: Pfizer Labs, Division of Pfizer Inc., New York, NY 10001, NDC 0069-0809-01 — Reason: cGMP Deviations: Product intended for quarantine was inadvertently distributed. — Status: Ongoing

    full page →fda recalls ↗

    Week of Mar 17, 2025

    1
    ›Mar 19, 2025recall537d agoAspen Biopharma Labs Pvt., Ltd. recall (Cls II)PFIZER INC

    Alprostadil Container Description: Amber color bottle — Reason: CGMP Deviations — Status: Ongoing

    full page →fda recalls ↗

    Week of Jun 30, 2025

    1
    ›Jul 2, 2025recall432d agoPfizer Inc. recall (Cls II)PFIZER INC

    DOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10 Fliptop Vials, Rx only, For Intravenous Use Only, Made in Italy, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC Carton: 0409-2344-02; NDC Vial: 0409-2344-62 — Reason: Discoloration; discolored solution from cracked vials — Status: Ongoing

    full page →fda recalls ↗

    Week of Aug 4, 2025

    2
    ›Aug 6, 2025recall397d agoPfizer Inc. recall (Cls II)PFIZER INC

    Bicillin L-A (penicllin G benzathine injectable suspension), 1,200,000 units per 2 mL, 2 mL-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001. Made in Austria, Carton NDC - 60793-701-10, Syringe NDC - 60793-701-02 — Reason: CGMP Deviations; particulates identified during visual inspection — Status: Ongoing

    full page →fda recalls ↗
    ›Aug 6, 2025recall

    Week of Aug 18, 2025

    1
    ›Aug 20, 2025recall383d agoPfizer recall (Cls II)PFIZER INC

    Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Austria, NDC 60793-851-01. — Reason: Subpotent drug — Status: Ongoing

    full page →fda recalls ↗

    Week of Aug 25, 2025

    2
    ›Aug 27, 2025recall376d agoPFIZER INC recall (Cls II)PFIZER INC

    Vial Label: Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045, USA. NDC 0409-4933-05. Case: NDC 0409-4933-10. — Reason: Lack of Assurance of Sterility. — Status: Ongoing

    full page →fda recalls ↗
    ›Aug 27, 2025recall

    Week of Feb 16, 2026

    9
    ›Feb 18, 2026recall201d agoF.H. INVESTMENTS, Inc. (dba Asteria Health) recall (Cls II)PFIZER INC

    ESTRADIOL, 25 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3025-32. — Reason: Presence of Foreign substance - potential presence of metal particulate matter — Status: Ongoing

    full page →fda recalls ↗
    ›Feb 18, 2026recall
    397d ago
    Pfizer Inc. recall (Cls II)PFIZER INC

    Bicillin L-A (penicillin G benzathine injectable suspension), 2,400,000 units per 4 mL, 4ml-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001, Made in Austria, Carton NDC- 60793-702-10 , Syringe NDC-60793-702-04 — Reason: CGMP Deviations; particulates identified during visual inspection — Status: Ongoing

    full page →fda recalls ↗
    376d ago
    PFIZER INC recall (Cls II)PFIZER INC

    Vial Label: 8.4% Sodium Bicarbonate Injection, USP, 50mEq/50 mL (1 mEq/mL), Rx only, Hospira, Inc., Lake Forest, IL 60045, USA, NDC 0409-6637-24. Case NDC: 00409-6637-14. — Reason: Lack of Assurance of Sterility. — Status: Ongoing

    full page →fda recalls ↗
    201d ago
    F.H. INVESTMENTS, Inc. (dba Asteria Health) recall (Cls II)PFIZER INC

    ESTRADIOL, 10 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3010-32. — Reason: Presence of Foreign substance - potential presence of metal particulate matter — Status: Ongoing

    full page →fda recalls ↗
    ›Feb 18, 2026recall201d agoF.H. INVESTMENTS, Inc. (dba Asteria Health) recall (Cls II)PFIZER INC

    ESTRADIOL, 20 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3020-32. — Reason: Presence of Foreign substance - potential presence of metal particulate matter — Status: Ongoing

    full page →fda recalls ↗
    ›Feb 18, 2026recall201d agoF.H. INVESTMENTS, Inc. (dba Asteria Health) recall (Cls II)PFIZER INC

    ESTRADIOL, 37.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3037-32. — Reason: Presence of Foreign substance - potential presence of metal particulate matter — Status: Ongoing

    full page →fda recalls ↗
    ›Feb 18, 2026recall201d agoF.H. INVESTMENTS, Inc. (dba Asteria Health) recall (Cls II)PFIZER INC

    ESTRADIOL, 12.5 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79599-3012-32. — Reason: Presence of Foreign substance - potential presence of metal particulate matter — Status: Ongoing

    full page →fda recalls ↗
    ›Feb 18, 2026recall201d agoF.H. INVESTMENTS, Inc. (dba Asteria Health) recall (Cls II)PFIZER INC

    ESTRADIOL,15 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3015-32. — Reason: Presence of Foreign substance - potential presence of metal particulate matter — Status: Ongoing

    full page →fda recalls ↗
    ›Feb 18, 2026recall201d agoF.H. INVESTMENTS, Inc. (dba Asteria Health) recall (Cls II)PFIZER INC

    ESTRADIOL, 18 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 3521, NDC: 79559-3018-32. — Reason: Presence of Foreign substance - potential presence of metal particulate matter — Status: Ongoing

    full page →fda recalls ↗
    ›Feb 18, 2026recall201d agoF.H. INVESTMENTS, Inc. (dba Asteria Health) recall (Cls II)PFIZER INC

    ESTRADIOL, 22 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3022-32. — Reason: Presence of Foreign substance - potential presence of metal particulate matter — Status: Ongoing

    full page →fda recalls ↗
    ›Feb 18, 2026recall201d agoF.H. INVESTMENTS, Inc. (dba Asteria Health) recall (Cls II)PFIZER INC

    ESTRADIOL, 6 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-3006-32. — Reason: Presence of Foreign substance - potential presence of metal particulate matter — Status: Ongoing

    full page →fda recalls ↗
    $MCK907.99-1.45%
    $PFE28.45-1.25%
    $PFE28.45-1.25%
    $PFE28.45-1.25%
    $PFE28.45-1.25%
    $PFE28.45-1.25%
    $PFE28.45-1.25%
    $PFE28.45-1.25%
    $PFE28.45-1.25%
    $PFE28.45-1.25%
    $PFE28.45-1.25%
    $PFE28.45-1.25%
    $PFE28.45-1.25%
    $PFE28.45-1.25%
    $PFE28.45-1.25%
    $PFE28.45-1.25%
    $PFE28.45-1.25%